A plasmid determining resistance to erythromycin (inducible), lincomycin, and vernamycin Ba was isolated from a strain of Streptococcus sanguis isolated from dental plaque of a patient who had been on erythromycin therapy for an extended period of time. The plasmid, designated pAM77, had a molecular weight of 4.5 x 106 and was present to the extent of one to two copies per bacterial chromosome. The plasmid could transform S. sanguis strain Challis.
Streptococcus sanguis is generally one of the predominant species in normal dental plaque (3, 4, 18) . Unlike Streptococcus mutans, which is frequently associated with dental caries, S. sanguis is believed to have low cariogenic potential (17) ; however, like other members of the viridans group, it has been iinplicated in cases of subacute bacterial endocarditis (11, 19, 29) . Drug-resistant strains in the viridans group have been reported (1, 32, 33) ; however, the literature is devoid of information on the involvement of R plasmids. In this report we describe a small plasmid in S. sanguis that determines resistance to erythromycin, lincomycin, and vernamycin Ba (a streptogramin B antibiotic) and show that this plasmid is capable of transforming S. sanguis strain Challis.
The materials and methods used in isolating and characterizing plasmid deoxyribonucleic acid (DNA) were essentially as described previously (9) . Cells (usually 30-to 50-ml cultures) were grown for several generations in APT broth (Difco Laboratories, Detroit, Mich.) containing ton, Mass.). To midlog-phase cells glycine was added to 5% (wt/vol), and incubation was continued for 45 min (31) . Cells were then harvested, treated with lysozyme-ethylenediaminetetraacetate, and lysed with Sarkosyl (9). (Lysozyme was at 1 mg/ml for 40 min.) Plasmid DNA was isolated as a satellite band after equilibrium centrifugation in CsCl gradients containing ethidium bromide (5, 7, 9) , and subsequent analyses involved sucrose density gradient centrifugation and electron microscopy (9) . Treatment with the restriction enzyme EcoRI involved the same enzyme concentrations, buffers, and incubation times previously described (35) . For treatment with the restriction enzyme HindIII, a reaction mixture consisted of 50 mM NaCl, 6 mM tris(hydroxymethyl)aminomethane-hydrochloride (pH 7.5), 6 mM MgCl2, 5 ,ug of bovine serum albumin, 1 p1 of HindIII, and approximately 1 ,ug of DNA. Reaction time was 1 h at 37°C. The restriction enzymes were obtained from BRL (Rockville, Md.). Analysis of fragments by agarose gel electrophoresis, using as markers EcoRI fragments of known size from bacteriophage lambda DNA, was as described elsewhere (35) . Transformation experiments were carried out as described by Davidson et al. (14) .
S. sanguis strain Al was isolated from dental plaque of a patient who had been on erythromycin therapy (500 mg/day) for approximately 1 year. This strain does not ferment mannitol or sorbitol and gives rise to colonies characteristic of S. sanguis on Todd-Hewitt agar (Difco) plates containing 5% sucrose. This strain exhibits resistance to erythromycin (minimum inhibitory concentration [MIC] in APT broth is 2 mg/ml), lincomycin (MIC is 200 ,g/ml), and vernamycin Ba (no inhibitory zone on plates using filter paper disks containing 20 Ag of drug). (Disks containing vernamycin Ba were kindly provided by B. Weisblum.) Thus, the strain exhibits the so-called MLS (macrolide, lincosamide, streptogramin B) phenotype (34) . Resistance to erythromycin was found to be of an inducible nature essentially the same as that previously described by us and others for certain resistant strains of Streptococcus pyogenes and Staphylococcus aureus (34, 36) . Strain Al is also resist-VOL. 13, 1978 ant to tetracycline, with the MIC being 12.5 ,ug/ml in APT broth. On the basis of filter paper disks (Difco) containing penicillin (2 U) and chloramphenicol (30 jig In the course of this study we also examined three other erythromycin-resistant strains (resembling S. sanguis) obtained from dental plaque of different patients on erythromycin therapy. Although all three strains exhibited a high level of resistance (similar to that of strain Al), plasmid DNA (covalently closed circular) could not be detected in any of them. Interestingly, these strains did not exhibit the same high level of resistance to lincomycin and vernamycin Ba, as was exhibited by strain Al, and, thus, they did not exhibit the MLS phenotype.
Plasmid DNA determining erythromycin resistance has been previously identified in S. au- (9, 12, 21) , S.
pyogenes (6, 25, 28) , and a group B streptococcus (20) . In several cases, the molecular masses of these plasmids are similar, with plasmid DNA being of a size of approximately 17 megadaltons (6, 9, 13, 26) . In one case we showed that plasmid pAM,8l from S. faecalis strain DS-5 was approximately 95% homologous with a plasmid of similar size in S. pyogenes strain AC-1 (36 
